Pronađeno: 1-5 / 5 radova

Autori: Schernthaner Guntram

>> Filter: Samo Article i Review

Naslov Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes (Editorial Material)
Autori Schernthaner Guntram  ...  Lalic Nebojsa M  ...  (broj koautora 17) 
Info CARDIOVASCULAR DIABETOLOGY, (2020), vol. 19 br. 1, str. -
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Evidence from routine clinical practice: EMPRISE provides a new perspective on CVOTs (Editorial Material)
Autori Schernthaner Guntram  ...  Lalic Katarina S  ...  (broj koautora 17) 
Info CARDIOVASCULAR DIABETOLOGY, (2019), vol. 18 br. 1, str. -
Projekat Boehringer Ingelheim
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov CARMELINA: An important piece of the DPP-4 inhibitor CVOT puzzle (Editorial Material)
Autori Schernthaner Guntram  Wanner Christoph  Jurisic-Erzen Dubravka  Guja Cristian  Gumprecht Janusz  Jarek-Martynowa Iwona R  Karasik Avraham  Lalic Nebojsa M  Mankovsky Boris N  Prazny Martin  Tankova Tsvetalina  Tsur Anat  Wascher Thomas C  Wittmann Istvan 
Info DIABETES RESEARCH AND CLINICAL PRACTICE, (2019), vol. 153 br. , str. 30-40
Projekat Fortis Pharma Communications; Boehringer Ingelheim
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov SGLT2 inhibitors in T2D and associated comorbidities differentiating within the class (Letter)
Autori Schernthaner Guntram  Drexel Heinz  Moshkovich Evgeny  Zilaitiene Birute  Martinka Emil  Czupryniak Leszek  Varkonyi Tamas  Janez Andrej  Ducena Kristine  Lalic Katarina S  Tankova Tsvetalina  Prazny Martin  Smircic-Duvnjak Lea  Sukhareva Olga  Sourij Harald 
Info BMC ENDOCRINE DISORDERS, (2019), vol. 19 br. , str. -
Projekat Boehringer Ingelheim (BI)
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Unrecognised cardiovascular disease in type 2 diabetes: is it time to act earlier? (Editorial Material)
Autori Schernthaner Guntram  ...  Lalic Nebojsa M  ...  (broj koautora 17) 
Info CARDIOVASCULAR DIABETOLOGY, (2018), vol. 17 br. , str. -
Projekat Boehringer Ingelheim; medical communication agency Fortis Pharma Communications
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Ispis zapisa u formatu:TXT | BibTeX